Search
  • mmahomed2

Phase I SBIR grant from the National Institute of General Medical Sciences

Valitor has been awarded a Phase I SBIR grant from the National Institute of General Medical Sciences. This project is designed to investigate the use of our multivalent protein technology to accelerate wound closure for a wider set of indications related to impaired wound healing.

0 views

Recent Posts

See All

Series A financing

Valitor is proud to announce the final close of our Series A financing, co-lead by the Berkeley Catalyst Fund and ShangPharma Innovations. This round oversubscribed our initial offering, and we raised

© Valitor, Inc 2020

  • LinkedIn - White Circle